|
KIAA0020 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.155200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.357800E-01 |
| Normal-vs-Stage2 |
6.908200E-01 |
| Normal-vs-Stage3 |
3.957400E-01 |
| Normal-vs-Stage4 |
2.087400E-01 |
| Stage1-vs-Stage2 |
5.536200E-01 |
| Stage1-vs-Stage3 |
8.967000E-01 |
| Stage1-vs-Stage4 |
5.794800E-01 |
| Stage2-vs-Stage3 |
6.187600E-01 |
| Stage2-vs-Stage4 |
3.857000E-01 |
| Stage3-vs-Stage4 |
7.685600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.390400E-01 |
| Normal-vs-AfricanAmerican |
3.475600E-01 |
| Normal-vs-Asian |
3.576200E-01 |
| Caucasian-vs-AfricanAmerican |
8.063000E-01 |
| Caucasian-vs-Asian |
3.891000E-01 |
| AfricanAmerican-vs-Asian |
3.997000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.283200E-01 |
| Normal-vs-Female |
9.078500E-03 |
| Male-vs-Female |
1.179360E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.524200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.141600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.519600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.185400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.691800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.893200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.635200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.743200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.947000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.583800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.662300E-02 |
| Normal-vs-Grade 2 |
2.016400E-01 |
| Normal-vs-Grade 3 |
6.321600E-01 |
| Normal-vs-Grade 4 |
2.601400E-01 |
| Grade 1-vs-Grade 2 |
1.575580E-01 |
| Grade 1-vs-Grade 3 |
6.202100E-02 |
| Grade 1-vs-Grade 4 |
4.871400E-01 |
| Grade 2-vs-Grade 3 |
2.501800E-01 |
| Grade 2-vs-Grade 4 |
5.935400E-01 |
| Grade 3-vs-Grade 4 |
3.421800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.057800E-02 |
| Normal-vs-ccB subtype |
6.594200E-01 |
| ccA subtype-vs-ccB subtype |
1.309210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.959400E-01 |
| Normal-vs-N1 |
5.373000E-01 |
| N0-vs-N1 |
9.341200E-01 |
|
|
